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Objective: We sought to evaluate whether the radial artery provides the same results
as the right internal thoracic artery in lateral wall revascularization in the long term.
Methods: From January 1992 to September 1996, 288 patients had myocardial
revascularization with the left internal thoracic artery anastomosed to the left ante-
rior descending coronary artery. The lateral wall was grafted with the radial artery
in 139 patients (group A) and with the right internal thoracic artery in 149 patients
(group B). Groups were different only because of older age and a higher incidence
of patients requiring urgent treatment in group A. Y grafting was used in 86.4% of
patients in group A and in 34.8% of patients in group B (P < .001). Anastomoses
per patient were similar in both groups (3.2 ± 0.8 vs 3.2 ± 0.9, P = 1.000).
Results: Thirty-day mortality was similar (2.1% vs 2.0%, P = .722). There were 15
late deaths in group A versus 11 in group B (P = .418). Cause of death was cardiac
related in 6 patients in group A versus 7 in group B. Late redo or percutaneous
transluminal coronary angioplasty was performed in 3 patients in group A and in 1
patient in group B (P = 0.538). Eight-year survival was 86.7% ± 2.9% in group A
versus 89.6% ± 2.8% in group B (P = .477); event-free survival was 84.2% ± 3.2%
versus 88.9% ± 2.9%, respectively (P = .430). The patency rate within 30 days was
99.1% in group A (105/106 left internal thoracic artery plus radial artery anasto-
moses) versus 100% in group B (52/52 bilateral internal thoracic artery anasto-
moses; P = .715). After a mean of 35 ± 28 months, the patency rate was 99.0% in
group A (100/101 left internal thoracic artery plus radial artery anastomoses) and
100% in group B (33/33 bilateral internal thoracic artery anastomoses, P = .560).
Conclusion: In the long-term, lateral wall grafting with the radial artery provides the
same clinical and angiographic results as right internal thoracic artery grafting.
The use of the radial artery (RA) as a graft for myocardial revascular-ization has become widely accepted because of good early andmidterm results.1-6 This graft is used in all the territories, with par-ticular regard to the lateral wall.
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The increasing use of the right internal thoracic artery (RITA) was
due to recent reports that focused on the improved quality of the late
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results when both thoracic arteries are used.7,8 Even if some
of these statements need to be confirmed by further studies,
it seems reasonable that grafting the left coronary system
with both thoracic arteries can provide better long-term
results.
We reviewed our experience to evaluate the long-term
results of the use of the RA or RITA in the lateral wall.
Materials and Methods
From January 1992 to September 1996, 288 patients underwent
myocardial revascularization with the left internal thoracic artery
(LITA) anastomosed to the left descending thoracic artery (LAD).
The lateral wall was grafted with the RA in 139 patients (group A)
and with the RITA in 149 patients (group B). Groups were basi-
cally similar, but age and incidence of urgent cases were higher in
group A. Some clinical characteristics are shown in Table 1.
Table 2 shows some technical details, as well as the conduits
used in both groups.
The number of anastomoses per patient performed on the lat-
eral wall was similar in both groups (1.13 ± 0.3 in group A vs 1.16
± 0.4 in group B, P = .475). The RA was used for sequential anas-
tomoses 34 (24.4%) times, and the RITA was used 29 (19.5%)
times (P = .388).
The RA was used in the presence of a stenosis of 70% or
greater, with expected high runoff (no previous myocardial infarc-
tion and target coronary vessel of reasonable size). The RITA was
used in younger patients when there was no indication for the RA
or according to the surgeon’s preference.
Surgical Technique
The RA was evaluated in all cases with the Allen test, and results
were considered negative when hand vascularization became nor-
mal in less than 6 seconds. The graft was harvested only from the
nondominant forearm. The RA was dissected through a skin inci-
sion starting 3 cm proximal to the wrist and ending 3 cm distal to
the elbow. All the side branches were occluded with Hemoclip
devices (Weck Closure Systems, Research Triangle Park, NC) or
ligated. The RITA was harvested as a pedicle in 26 patients and
skeletonized in 123 patients. Surgical technique has already been
reported.9
In group A the RA was proximally anastomosed to the LITA in
120 patients and to the ascending aorta in 19 patients. When the
aorta was the RA blood source, the proximal anastomosis was per-
formed during crossclamping. When possible, a papaverine solu-
tion (1 mg/1 mL) was injected inside the RA graft, which was then
distally clipped to allow pharmacologic dilation.
The LITA was used in all cases as an in situ graft. The RITA
was used in situ in 91 patients and as a free graft in the remaining
58 patients (ie, as a Y graft from the LITA in 53 patients and
directly from the aorta in 5 patients). The surgical technique of Y
grafting has already been described.10,11 When in situ, all the
RITAs reached the lateral wall by passing over the aorta.
All the patients were operated on with cardiopulmonary bypass
and intermittent antegrade warm blood cardioplegia.12
TABLE 1. Preoperative data
Group A (n = 139) Group B (n = 149) P value
Age (y) 62.8 ± 7.9 60 ± 8.6 .003
≥75 y 4 (2.9%) 5 (3.3%) .885
Female sex 15 (10.7%) 17 (11.4%) .999
Diabetes 35 (25.1%) 38 (27.3%) .772
Urgent 54 (38.8%) 39 (26.2%) .03
Previous AMI 89 (64%) 84 (60.4%) .612
Redo operation 7 (5.0%) 6 (4.0%) .901
EF 59 ± 11.8 57.4 ± 13.9 .295
≤35% 6 (4.3%) 11 (7.3%) .405
2-vessel disease 25 (17.9%) 28 (18.8%) .964
3-vessel disease 114 (82.1%) 121 (81.2%) .964
Left main stem 18 (12.9%) 19 (12.7%) .9
AMI, Acute myocardial infarction; EF, ejection fraction.
TABLE 2. Technical data
Group A (n = 139) Group B (n = 149) P value
Anastomoses/patient 3.2 ± 0.8 3.2 ± 0.9 1
CPB time (min) 68.4 ± 20.8 63.7 ± 19 .011
Aortic crossclamping 53.9 ± 16.2 53.3 ± 16.1 .753
time (min)
LITA 139 (100%) 149 (100%) –
RITA 38 (27.3%) 149 (100%) <.001
RA 139 (100%) 5 (3.3%) <.001
RGEA 47 (33.8%) 63 (42.3%) .173
IEA 15 (10.7%) 4 (2.7%) .011
SVG 13 (9.3%) 8 (5.4%) .296
TAMR 126 (90.6%) 141 (94.6%) .282
CPB, Cardiopulmonary bypass; RGEA, right gastroepiploic artery; IEA,
inferior epigastric artery; SVG, saphenous vein graft; TAMR, total arterial
myocardial revascularization.
TABLE 3. Results
Group A (n = 39) Group B (n = 149) P value
Deaths 3 (2.1%) 3 (2.0%) .722
CVA 2 (1.4%) 3 (2.1%) .998
AMI 1 (0.7%) 1 (0.7%) .479
Early major events 6 (4.3%) 6 (4.3%) .771
Inotropes 2 (1.4%) 2 (1.4%) .616
CK-MB peak 48 ± 54 47 ± 41 .845
Bleeding (mL/12 h) 597 ± 304 546 ± 323 .182
Transfused patients 44 (31.6%) 29 (20.9%) .053
Atrial fibrillation 20 (14.6%) 31 (22.3%) .127
Sternal wound problem 6 (4.3%) 4 (2.7%) .675
Hospital stay (d) 8.2 ± 8.3 5.9 ± 2.6 .001
ICU stay (h) 30.6 ± 20 27.6 ± 37.1 .399
CVA, Cerebrovascular accident; AMI, acute myocardial infarction; CK-
MB, creatine kinase muscle brain; ICU, intensive care unit.
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Postoperative Course
From the operating room, patients were admitted to the intensive
care unit and from there to the regular ward. They were followed
up in our outpatient clinic 3, 6, and 12 months after their opera-
tions and each year thereafter. The more recent information was
obtained by calling the patients or the referring cardiologist. If
patients agreed, a coronary angiogram was performed during a
brief hospitalization. The quality of the anastomoses was graded
according to the method of FitzGibbon and colleagues.13 Follow-
up was 100% complete.
Statistical Analysis
Results are expressed as mean values ± SD unless otherwise indi-
cated. Statistical analysis comparing 2 groups was performed with
unpaired 2-tailed t testing for means or with the χ2 test for cate-
gorical variables. Survival and event-free survival curves were
obtained with the Kaplan-Meier method (SPSS software; SPSS,
Inc, Chicago, Ill). The statistical significance was calculated with
the log rank test.
Results
Table 3 shows some postoperative data. Six (2.1%) patients
died during the postoperative course: 3 (2.1%) in group A and
3 (2.0%) in group B (P .722). Causes of death were intestinal
bleeding (n = 1) and acute myocardial infarction (n = 1) in
group A and intestinal ischemia (n = 1), acute mediastinitis (n
= 1), and acute myocardial infarction (n = 1) in group B.
There was no difference in the incidence of acute myocardial
infarction, cerebrovascular accidents, and atrial fibrillation or
in the amount of bleeding. However, the transfusion rate was
higher in group A than in group B (31.6% vs 20.9%, P =
.053). Mean intensive care unit stay was similar in both
groups, whereas mean hospital stay was higher in group A.
All the patients were discharged home with 60 mg of
oral diltiazem taken 3 times a day for 1 month and 100 mg
of aspirin taken once a day.
Follow-up
Twenty-six (9.2%) patients died after a mean of 27 ± 22
months (minimum-maximum, 2-70 months): 15 in group A
and 11 in group B. Causes of deaths (Table 4) were cardiac
in 13 patients (6 in group A and 7 in group B, P = .901) and
noncardiac in the remaining 13 patients (9 in group A and 4
in group B, P = .200). Nine years after the operation, 8-year
survival was 88.1% ± 2.0% (group A: 86.7% ± 2.9% vs
group B: 89.6% ± 2.8%, P = .477, Figure 1).
Mean follow-up of the 256 survivors was 77 ± 16
months (range, 54-110 months). After a mean interval of 41
± 30 months after the operation, 4 patients (3 in group A
and 1 in group B) needed a redo operation (surgical in 1
patient in group A and interventional in the remaining 3
patients [2 in group A and 1 in group B]). Eight-year event-
free survival was 86.3% ± 2.2% (group A: 84.2% ± 3.2% vs
group B: 88.9% ± 2.9%, P = .430, Figure 2).
TABLE 4. Causes of late death
Group A (n = 136) Group B (n = 146) P value
Cardiac 6 (44.4%) 7 (4.8%) .901
AMI 5 2
Sudden death 5 4
Congestive heart failure 0 1
Noncardiac 9 (6.6%) 4 (2.7%) .200
Gastric hemorrhage 1 0
Malignancy 7 1
Stroke 1 3
Total 15 (11.0%) 11 (7.5%) .418
AMI, Acute myocardial infarction.
Figure 1. Eight-year actuarial survival: group A (solid lines) versus
group B (dashed lines).
Figure 2. Eight-year event-free survival: group A (solid lines) ver-
sus group B (dashed lines).
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Angiographic Follow-up
Sixty-eight (23.6%) patients had an early angiogram within
30 days after the operation (mean, 8 ± 3 days): 46 (33.8%)
in group A and 22 (15.1%) in group B. Five patients in
group A and 2 in group B had both early and late angio-
graphic studies. The quality of the anastomoses was graded
according to the method of FitzGibbon and colleagues.13
The patency rate (grade A plus B) and the nonrestrictive
patency rate (grade A) of LITA-RA and LITA-RITA distal
anastomoses were similar: 99.1% (105/106) in group A and
100% (52/52) in group B (P = .715). All the RA-LITA and
RITA-LITA intermediate anastomoses were patent in the
patients who had a postoperative follow-up angiogram.
After a mean of 35 ± 28 months (range, 6-95 months), 57
(22.5% of the survivors) patients had a new angiogram. The
patency rate (grade A and B) of the LITA-RA anastomoses
was 99% (100/101) (Figure 3, A), which is similar to the
patency rate of the LITA-RITA anastomoses (100%
[33/33], P = .560; Figure 3, B). Grade A anastomoses were
97% for the LITA-RA anastomoses and 100% for the LITA-
RITA anastomoses (33/33, P = .740). All the RA-LITA and
RITA-LITA intermediate anastomoses were fully patent.
Table 5 summarizes the angiographic results. In this cohort
of patients, no RAs showed a string sign.
Discussion
The use of the RA as a graft for myocardial revasculariza-
tion started in the 1970s14 but was discontinued because of
the high occlusion rate.15 Acar and colleagues1 successfully
reproposed this conduit in the early 1990s. Good midterm
clinical and angiographic results were reported,2,3,5,6,11,16-23
and today the RA is a popular conduit.
When bilateral ITA grafting become more diffuse, the
problem of the correct use of the RITA was predominant.
The in situ RITA to the right coronary artery system was
proved to have the same outcome as the saphenous vein
graft.24 Grafting the in situ RITA to the LAD forces the con-
duit to cross the midline in a very dangerous manner at the
level of the aortic valve and of the pulmonary infundibulum.
Bringing the RITA to the lateral wall is less dangerous. The
Figure 3. Postoperative angiogram. A, Eighty-five months after the
operation, the RA, proximally anastomosed to the LITA, is grafted
to the obtuse marginal branch. B, Fifty-six months after the opera-
tion, the RITA, proximally anastomosed to LITA, is grafted to the
obtuse marginal branch.
A
B
TABLE 5. Angiographic results
Conduits Grade A Grade B Grade 0
Early: 8 ± 3 d
LITA-RA* 105/106 (99.1%) 0/106 (–) 1/106 (0.9%)
LITA-RITA† 52/52 (100%) 0/52 (–) 0/52 (–)
RA-LITA anastomoses* 41/41 (100%) 0/41 (–) 0/51 (–)
RITA-LITA anastomoses† 22/22 (100%) 0/22 (–) 0/22 (–)
RITA* 12/12 (100%) 0/12 (–) 0/12 (–)
RGEA 19/20 (95%) 0/20 (–) 1/20 (5%)
IEA 4/4 (100%) 0/4 (–) 0/4 (–)
SVG 4/4 (100%) 0/4 (–) 0/4 (–)
At 35 ± 28 mo
LITA-RA* 98/101 (97%) 2/101 (2%) 1/101 (1%)
LITA-RITA† 33/33 (100%) 0/33 (–) 0/33 (–)
RA-LITA anastomoses* 40/40 (100%) 0/40 (–) 0/40 (–)
RITA-LITA anastomoses† 12/12 (100%) 0/12 (–) 0/12 (–)
RITA* 5/5 (100%) 0/5 (–) 0/5 (–)
RGEA 20/24 (83.3%) 1/24 (4.2%) 3/24 (12.5%)
IEA 12/13 (92.3%) 0/13 (–) 1/13 (7.7%)
SVG 11/12 (91.7%) 0/12 (–) 1/12 (8.3%)
RGEA, Right gastroepiploic artery; IEA, inferior epigastric artery; SVG,
saphenous vein graft.
*Group A.
†Group B.
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retroaortic route was proposed by Puig and colleagues25
and was demonstrated to be safe by many authors.26,27 The
overaortic route passes very high at the distal ascending
aorta and can be covered by the thymic fat. It seems to be
less dangerous in case of a resternotomy.
However, the increased use of the RITA was related to its
use as a free graft, not from the aorta (its patency rate is sig-
nificantly lower than the in situ graft)28 but connected to the
LITA as a T29 or a Y10 composite graft.
With the LAD as the target vessel for the LITA, the use
of the RITA is directed mainly to the lateral wall. Because
this territory is also the main target of RA grafting, we ret-
rospectively analyzed 2 groups of patients, all with a LITA
to the LAD and a RITA or an RA in the lateral wall.
Our study showed that, after a mean follow-up of 77 ±
16 months, it was not possible to find any difference
between the 2 groups, in terms of both early and late clini-
cal results. Angiographic results were also similar and, after
a mean of 35 ± 28 months, comparing LITA-RA and LITA-
RITA anastomoses, the patency rate was 99% versus 100%,
and the nonrestrictive patency rate was 97% versus 100%.
Interestingly, the intermediate anastomoses between the RA
or the RITA with the LITA were all patent, demonstrating
that the addition of an anastomosis does not impair the pos-
sibility of a satisfying late patency rate.
In our experience no RA showed a string sign. It is diffi-
cult to understand why. The only possibility is that we tried
to follow carefully, since the beginning, strict indications
for RA grafting. Royse and colleagues30 demonstrated that
string sign is related to a low-grade coronary stenosis of the
target vessel (56% ± 5%). Since the first articles we pub-
lished on this topic,2 we believed that the RA had to be used
only if a severe stenosis was present, and we carefully fol-
lowed this policy in all cases. Furthermore, it is possible
that patients who refused a new angiogram could have this
abnormality. However, it seems that, after the first months
after the operation, the RA loses its peculiar characteristics
of increased vasomotricity,3 and this can be at the basis of
the reduced incidence of this angiographic aspect of the RA
graft.
In conclusion, after a maximum follow-up of 8 years,
clinical and angiographic results of RA and RITA grafting
in the lateral wall, if the LITA is anastomosed to the LAD,
are similar. This fact enhances the possibility of choice of
the appropriate graft when coronary revascularization with
multiple arterial grafting is scheduled.
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Discussion
Dr Alfred Tector (Milwaukee, Wis). After it was shown that
bypassing the LAD with the LITA significantly enhanced long-
term survival after coronary bypass operations, some surgeons
became interested in multiple or total coronary artery revascular-
ization as an attempt to enhance outcomes. Dr Calafiore and his
associates have demonstrated excellent survival and a reduced
need for reintervention in 288 patients who were revascularized
with multiple arterial bypass grafts. The authors accomplished
near-perfect graft patency, as demonstrated with angiography,
when using either the RITA or the RA to bypass the coronary
arteries supplying the lateral wall of the heart in 68 patients stud-
ied 5 to 11 days and 57 patients observed 7 to 63 months after their
operation. This occurred whether the proximal end of the RA or
the RITA was connected to the LITA or the aorta or whether it was
used as an in situ graft. The authors do not list the patency of the
LITA-LAD anastomoses; however, I assume it is similar to that of
the lateral wall grafts.
I have several questions for Dr Calafiore. What percentage of
total patients undergoing coronary bypass grafting by your group
does this series of patients represent? Were any of the patients in
the early group who had postoperative graft visualization also
studied late?
You state that coronary arteries bypassed with RA grafts were
carefully selected and had 70% stenosis or greater and were larger
and had good runoff. Other than the younger patients mentioned in
the manuscript, what were your criteria for choosing the RITA
grafts?
What technical and selective features do you think were most
beneficial to you in obtaining outstanding patency with these
grafts?
Finally, you point out that all of these revascularization proce-
dures were performed with cardiopulmonary bypass, but I am sure
many people wonder whether you think you could achieve equally
good results using off-pump coronary artery bypass techniques.
Dr Calafiore. Thank you, Dr Tector, for your comments.
The patency rates of the LITA anastomosed to the LAD in this
group were very high. There was only one anastomosis that had
stenosis in the late angiographic study. Basically, if we compare
the LITA to the RA, there is always a trend and a higher patency
in the LITA instead of the RA.
In the 4 years of the study, we operated on something like 1200
patients with coronary disease. Therefore, this is not more than
20%, perhaps less, of our global experience.
If I understood correctly, you asked whether I think I can
achieve the same results with off-pump operations. This is an
interesting question. We did not have such a long-term follow-up,
but at least I can tell you that in our experience today, 50% or more
of the patients who have a total arterial revascularization have off-
pump operations. When we have the time to better understand the
midterm or long-term results, I will be able to answer your ques-
tion, but at this moment, there is no difference between the 2
groups.
You had one other question, Dr Tector.
Dr Tector. The other question was what technical and selective
features do you think were most beneficial to you in obtaining out-
standing patency with these grafts?
Dr Calafiore. I think that the problem is also selection of the
vessel. Basically, I do not believe in extensive revascularization
performed with 5 or more grafts. Generally, our policy is to graft
the vessels with a good size and a good territory. I think that this
is just a key point for having a good patency rate. Of course, there
is the technical experience of the surgeon. We must not forget that
the surgeon is always a key point for a good operation.
Dr Lawrence Cohn (Brookline, Mass). In the first session of
this meeting, we listened to the group in St Louis discuss the RA.
What has been your experience with only moderately severe coro-
nary stenosis using those grafts? There is a little concern that the
RA for the right coronary, moderate stenosis, or both does not
have great long-term patency.
Dr Calafiore. When we started to use the RA, we thought that
the problem of the choice of the territory was the key point for the
good patency rate of this artery. I think that our good results
depend on our strict patient selection. We always preferred to use
a good-sized coronary artery with severe stenosis and without
myocardial infarction. I think that this is very important.
The reason for the lower patency rate in the right coronary ter-
ritory is perhaps that the right coronary territory in the great major-
ity of the patients who have operations is the most diseased
because the great majority of them had a previous inferior myocar-
dial infarction. The viable territory is not very big, and there are
many small vessels. I think that a lot of grafts will fail in the right
coronary territory. The circumflex territory is surely the best one,
except, of course, the LAD, for an RA graft, but the LAD is the
best for the LITA.
Dr Reida M. El Oakley (Singapore). Pharmacologic manage-
ment of RAs is a highly controversial area. Could you please tell
us how you manage the RA from the pharmacologic point of view
during and after operation?
Dr Calafiore. In the beginning we were focused on the phar-
macologic treatment of the patient with the RA. If you remember,
the first attempts with the RA failed because of a lot of technical
aspects and because the pathophysiology of the artery was not
known. When the experience started again, we started to use cal-
cium blockers extensively. Today I believe that this is not so impor-
tant. Of course, during operations, we touch the conduit, but now it
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has been demonstrated that nitroglycerin is more effective than cal-
cium blockers to relieve spasm. Today we are using nitroglycerin
intravenously, and in the first weeks we are still giving calcium
blockers, but I think that this aspect is not the most important issue
for the patency rate of the RA. I think that the technical aspect and
the choice of the correct territory is the key point for the satisfying
patency rate. The pharmacologic aspect becomes less important.
Dr Brian Buxton (Heidelberg, Australia). You are a few years
ahead of us with the number of RA grafts and ITA grafts that you
have been performing. I have the impression that the RA does not
quite match up to the free RITA, although your results here sug-
gest that they do. If you had a crystal ball, what would you think
would happen over an extended period of time?
Do you think it is just as valid to use an RA as the Y graft com-
ponent, or do you think that there is still a very important role for
Dr Tector’s operation, in which the RITA is attached to the side of
the LITA? In other words, do you think there is any difference? I
know you show there is none.
Dr Calafiore. I think that today the best operation always is to
use the 2 thoracic arteries, perhaps in the Y or T graft, as Dr Tector
proposed. But what I think is important is the message that the RA
is a second arterial conduit that can be used with very good results.
I think that many surgeons will use a second conduit if this is an
RA because it has a good size and can be harvested contempora-
neously with the LITA. Many surgeons will not use the RITA
every day in every patient. Today my policy is still to use 2 tho-
racic arteries for the great majority of patients. However, I think
that the knowledge that the patency rate of the RA in selected
cases is pretty good is important information and a positive mes-
sage to send.
Dr O. Wayne Isom (New York, NY). There was one thing you
did not mention. Did you notice, in the patients with bilateral ITA
harvesting, any increase in sternal infection?
Dr Calafiore. In 1994 and 1995 we completely changed the
method of dissecting ITAs that were skeletonized during harvest-
ing. It was demonstrated, both in necropsies and studying the ster-
nal vascularization after bilateral ITA harvesting, that the
skeletonization preserves the sternum from the devascularization
that follows the harvesting of both ITAs. We used a lot of RAs in
the first part of our experience because the RITA was not used in
diabetic patients. Now we are using the RITA in all the patients
who have so-called risk factors such as obesity and diabetes.
Dr Isom. You do not notice any difference in infection?
Dr Calafiore. No. There is no difference in the infection rate
or in the major sternal problems in patients with 1 or 2 ITAs if
skeletonized.
Notice from the American Board of Thoracic Surgery
regarding trainees and candidates for certification who are
called to military service related to the war on terrorism
The Board appreciates the concern of those who have received emergency call to military
service. They may be assured that the Board will exercise the same sympathetic considera-
tion as was given to candidates, in recognition of their special contributions to their country,
during the Viet Nam conflict and the Persian Gulf conflict with regard to applications, exami-
nations, and interruption of training. If you have any questions about how this might affect
you, please call the Board office at 847-475-1520.
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